Terns Pharmaceuticals (TERN) News Today

Terns Pharmaceuticals (NASDAQ:TERN) Trading 6.1% Higher

Terns Pharmaceuticals (NASDAQ:TERN) Shares Gap Up to $8.95

BMO Capital Markets reaffirmed an "outperform" rating and set a $26.00 price objective (up from $19.00) on shares of Terns Pharmaceuticals in a research note on Monday.

Terns Pharmaceuticals, Inc. (NASDAQ:TERN - Get Free Report) was the recipient of a large increase in short interest in August. As of August 31st, there was short interest totalling 2,660,000 shares, an increase of 47.8% from the August 15th total of 1,800,000 shares. Approximately 5.6% of the company's stock are short sold. Based on an average trading volume of 1,780,000 shares, the days-to-cover ratio is currently 1.5 days.

Terns Pharmaceuticals (NASDAQ:TERN) Sees Strong Trading Volume

Terns Pharmaceuticals, Inc. (NASDAQ:TERN - Get Free Report) CFO Mark J. Vignola sold 10,000 shares of the firm's stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $11.00, for a total value of $110,000.00. Following the sale, the chief financial officer now directly owns 91,940 shares of the company's stock, valued at $1,011,340. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Terns Pharmaceuticals (NASDAQ:TERN) Stock Price Down 4% After Insider Selling

Terns Pharmaceuticals, Inc. (NASDAQ:TERN - Get Free Report) Director Jill M. Quigley sold 17,235 shares of the stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $10.00, for a total transaction of $172,350.00. Following the completion of the transaction, the director now owns 15,000 shares in the company, valued at approximately $150,000. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Terns Pharmaceuticals (NASDAQ:TERN) Shares Gap Down to $11.23

Terns Pharmaceuticals (NASDAQ:TERN) Reaches New 52-Week High After Analyst Upgrade

JMP Securities raised their target price on Terns Pharmaceuticals from $15.00 to $20.00 and gave the stock a "market outperform" rating in a report on Tuesday.

Terns Pharmaceuticals (NASDAQ:TERN) Shares Gap Up to $7.81

Terns Pharmaceuticals, Inc. (NASDAQ:TERN - Get Free Report) saw some unusual options trading activity on Thursday. Stock traders acquired 3,105 call options on the company. This represents an increase of 228% compared to the typical volume of 947 call options.

JMP Securities reaffirmed a "market outperform" rating and issued a $15.00 price objective on shares of Terns Pharmaceuticals in a report on Tuesday.

Terns Pharmaceuticals, Inc. (NASDAQ:TERN - Get Free Report) saw a significant decrease in short interest in August. As of August 15th, there was short interest totalling 1,800,000 shares, a decrease of 32.1% from the July 31st total of 2,650,000 shares. Based on an average daily volume of 1,250,000 shares, the days-to-cover ratio is currently 1.4 days. Approximately 3.8% of the shares of the stock are short sold.

Terns Pharmaceuticals (NASDAQ:TERN) Shares Down 5%

Terns Pharmaceuticals (NASDAQ:TERN) Stock Price Up 7.3%

Terns Pharmaceuticals, Inc. (NASDAQ:TERN - Get Free Report) was the target of a large growth in short interest in July. As of July 31st, there was short interest totalling 2,650,000 shares, a growth of 33.2% from the July 15th total of 1,990,000 shares. Based on an average daily volume of 1,220,000 shares, the days-to-cover ratio is currently 2.2 days. Approximately 5.5% of the shares of the company are sold short.

Salem Investment Counselors Inc. bought a new position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 371,600 shares of the company's stock, valued at

Terns Pharmaceuticals (NASDAQ:TERN - Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.31) EPS for the quarter, beating the consensus estimate of ($0.35) by $0.04.